Bone-Modifying Agents in Early-Stage and Advanced Breast Cancer

PURPOSE OF REVIEW: Bone-modifying agents have an important role in the treatment of patients with bone mineral density loss, early-stage breast cancer to reduce risk of recurrence, and metastatic breast cancer with bone involvement. Here we review mechanisms of action of these agents and clinical in...

Descripción completa

Detalles Bibliográficos
Autores principales: Heeke, Arielle, Nunes, Maria Raquel, Lynce, Filipa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2018
Materias:
Systemic Therapies (M Liu and T Haddad, Section Editors)
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6276066/
https://www.ncbi.nlm.nih.gov/pubmed/30581537
http://dx.doi.org/10.1007/s12609-018-0295-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6276066/
https://www.ncbi.nlm.nih.gov/pubmed/30581537
http://dx.doi.org/10.1007/s12609-018-0295-6

Ejemplares similares